Device Trial Radar · NCT07122518
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
35
Planned (sponsor's estimate)
Start
Jun 23, 2026
Primary completion
Jun 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- Cordis US Corp.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Congenital Cardiovascular Interventional Study Consortium (CCISC)
- First posted
- Aug 14, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the clinical investigation is to characterize clinical outcomes and to assess the real-world use of the commercial PALMAZ MULLINS XD™ Pulmonary Stent.
Conditions
- Pulmonary Artery Stenosis
Interventions
PALMAZ MULLINS XD™ Pulmonary StentDevice
The PALMAZ MULLINS XD™ Pulmonary Stent is indicated for the non-emergency treatment of pulmonary artery stenosis in pediatric patients who are at least 10kg in weight with two ventricle anatomy. The PALMAZ MULLINS XD™ Pulmonary Stent is a balloon-expandable, laser cut stent made from 316L stainless steel tubing. The stent is supplied unmounted and in five (5) nominal unexpanded lengths: 19 mm, 25 mm, 29 mm, 39 mm, and 59 mm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical Success (Successful use of the study device without additional, unplanned device or procedure-related surgery/re-intervention)Time frame: Start time of index procedure through time of discharge/study completion, usually within ~48 hours from end time of index procedure
- Patency (Angiographically-determined increase in stented vessel minimum pulmonary artery diameter by ≥ 50% of the pre-stent diameter)Time frame: Index procedure (start time to end time)
- Safety Outcome (Incidence of Treatment-Emergent Serious Adverse Events)Time frame: Time of enrollment (device implant during index procedure) through time of discharge/study completion, usually within ~48 hours from end time of index procedure
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
UC Davis Children's Hospital
Sacramento, California · Not yet recruiting
Children's Healthcare of Atlanta
Atlanta, Georgia · Not yet recruiting
Children's Hospital of Michigan
Detroit, Michigan · Recruiting
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.